
Dr Aileen Fernandez
@aileenilianaphd
Liquid Product Specialist | Translational cancer researcher | #LatinaInSTEM #afroLatina #Blackincancer š©š“ *Tweets are my own*
ID: 1193988927738306560
11-11-2019 20:28:45
5,5K Tweet
1,1K Followers
1,1K Following




Keeping order in the courtroom, our co-chairs Drs. Tina Cascone and Stephen V Liu, MD will serve as the ābailiffsā for The Trial of the Century at this 2-day CE-accredited conference. Will the "defense" make a compelling case, or will objections be sustained? Join us April 10-12 at



One bonus of New York Lung Cancer Foundation Summit- getting to meet Narjust Florez, MD, FASCO IRL and scoring my very own #HearHer pin!!




Expert talk on ctDNA by Stefania Morganti breast cancer- we need more data on what to do for pts with MRD in the adjuvant setting Stefania Morganti, MD Dana-Farberās Breast Oncology Center VIRGINIA KAKLAMANI


A marathon presentation on ADCs by Paolo Tarantino - a rapidly evolving space MD Education Dana-Farberās Breast Oncology Center VIRGINIA KAKLAMANI


āWhen research funding is cut, #patients pay the price and a generation of discoveries is lost. We must protect the independence and integrity of science and remain focused on the #patients. This is not someone elseās problem, but oursā by AACR President Patricia M. LoRusso AACR #AACR25 Yale Cancer Center


What a magical night! We raised over $100,000 for single mothers living with MBC! Thank you Ocean House for providing this beautiful venue. And a special thank you to our sponsors, donors & the incredible oncologists who made the event so successful!



In 2022, Janice Cowden , Dear Dr. Researcher, PhD, & I sat together to hear the much anticipated DESTINY-Breast 04 trial results. As cancer survivors, when we see data, we see the patients behind the data, we ARE the patients behind the data, & weāre grateful to still be here! #ASCO25



First-line Sacituzumab + Pembrolizumab improves PFS in 1st Line TNBC. šØšā¼ļø Crossover 80% Sacituzumab Offered! Very few patients with prior IO, few who relapsed within 6-12 months. OS looks similar but early days. #bcsm great job Sara Tolaney !!



